Holly Springs, NC, US

Fujifilm building exterior

Holly Springs, North Carolina is home to FUJIFILM Biotechnologies’ largest end-to-end cell culture biopharmaceutical CDMO facility in North America.

Holly Springs At a Glance

energy sources icon
0 million

square feet

water drop icon
0 +

Employees

bioreactor
0

20,000 L bulk drug substance

syringe icon
0

drug-product batch capacity

sustainability icon
0 %

of power is carbon-free

waste bin icon
0 %

waste diversion in construction

“The Holly Springs site was built using the blueprint from the first expansion in Denmark aligning facility design, equipment, processes, and procedures – [this is the company’s network philosophy, known as kojoX™]. This equivalency enables teams to operate seamlessly across the network and allows improvements to be developed and deployed in parallel, building on established performance rather than reinventing approaches site-by-site.” 

LAURIE BRAXTON, Senior Vice President, Head of Holly Springs, NC site, FUJIFILM Biotechnologies 

Partnerships

As part of the local community, we are committed to workforce development, transportation improvements, sustainability, and community involvement, building the quality of place that makes Holly Springs unique. Our local partners include: 

BTEC

  • Economic Development Partnership of NC
  • Holly Springs Chamber of Commerce
  • Japan-America Society of NC
  • NC Business Committee on Education
  • NC Biotechnology Center
  • NC Community Colleges
  • NC Department of Commerce
  • Raleigh Chamber of Commerce
  • Wake Early College
  • Regional Transportation Alliance
  • Triangle Women in STEM
  • Wake Tech
  • Wake County Chamber of Commerce

Edge

  • ISPE Carolina – South Atlantic Chapter
  • Town of Holly Springs
  • NC Central University
  • NC State University
  • The NC Biosciences Organization
  • Wake County Economic Development
  • Wake County Public School System
  • RDU – International Airport
  • Research Triangle Regional Partnership
  • Business Sustainability Roundtable